Daily Stock Analysis, CYTX, Cytori Therapeutics Inc, priceseries

Cytori Therapeutics Inc. Daily Stock Analysis
Stock Information
Open
2.06
Close
2.02
High
2.15
Low
2.01
Previous Close
2.04
Daily Price Gain
-0.02
YTD High
24.45
YTD High Date
Jan 31, 2019
YTD Low
1.78
YTD Low Date
Nov 20, 2019
YTD Price Change
-13.98
YTD Gain
-87.38%
52 Week High
24.45
52 Week High Date
Jan 31, 2019
52 Week Low
1.78
52 Week Low Date
Nov 20, 2019
52 Week Price Change
-13.71
52 Week Gain
-87.16%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 18. 2017
825.00
Jan 19. 2017
882.50
1 Trading Days
6.97%
Link
LONG
Oct 4. 2017
196.80
Oct 12. 2017
227.46
6 Trading Days
15.58%
Link
LONG
Jan 18. 2018
210.00
Jan 19. 2018
222.00
1 Trading Days
5.71%
Link
LONG
Jul 6. 2018
82.51
Jul 9. 2018
88.23
1 Trading Days
6.93%
Link
LONG
Aug 21. 2018
24.79
Aug 24. 2018
26.20
3 Trading Days
5.71%
Link
LONG
Apr 8. 2019
19.38
Apr 9. 2019
20.91
1 Trading Days
7.94%
Link
LONG
Aug 23. 2019
8.30
Sep 5. 2019
11.51
8 Trading Days
38.72%
Link
Company Information
Stock Symbol
CYTX
Exchange
NasdaqCM
Company URL
http://www.cytori.com
Company Phone
8584580900
CEO
Marc H. Hedrick
Headquarters
California
Business Address
3020 CALLAN ROAD, SAN DIEGO, CA 92121
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001095981
About

Cytori Therapeutics, Inc. is a late stage cell therapy company. that engages in the developement of autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions. Data from preclinical studies and clinical trials suggest that Cytori Cell Therapy acts principally by improving blood flow, modulating the immune system and facilitating wound repair. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in San Diego, CA.

Description

Cytori Therapeutics, Inc., a biotechnology company, develops cellular therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy consisting of a heterogeneous population of specialized cells, including stem cells for the treatment of patients with scleroderma hand dysfunction, orthopedic disorders, urinary incontinence, and thermal burns combined with radiation injury. It also offers Celution System devices, proprietary enzymes, and sterile consumable sets to commercial customers, as well as for research customers developing new therapeutic applications for Cytori Cell Therapy in Europe, Japan, and other regions. In addition, the company provides StemSource devices, including a cryogenic freezer, measuring and monitoring equipment, and a database patient tracking system, as well as offers consulting, installation, and training services. Cytori Therapeutics, Inc. markets its products to hospitals, clinics, tissue banks, and stem cell banking companies through direct sales reps, distributors, and partners worldwide. The company was founded in 1996 and is headquartered in San Diego, California.